ConvaTec Group Net Income Over Time
| 2CV Stock | EUR 2.64 0.02 0.76% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ConvaTec Group Performance and ConvaTec Group Correlation. ConvaTec |
Cross Equities Net Income Analysis
Compare ConvaTec Group PLC and related stocks such as Cerence, TELES Informationstech, and BIOTIME Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0S6 | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | (18.3 M) | 45.9 M | (310.8 M) | (56.3 M) | (588.1 M) | (18.7 M) | (16.8 M) | (17.7 M) |
| TLIK | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 521 K | (3 M) | 3.9 M | 824.5 K | 267.5 K | (1.7 M) | (1.9 M) | (835.2 K) | (751.7 K) | (714.1 K) |
| BT3 | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | (20 M) | (46 M) | (11.7 M) | (20.6 M) | (43 M) | (26.3 M) | (21.5 M) | (18.6 M) | (16.7 M) | (17.6 M) |
| MS9 | (487 B) | (487 B) | (487 B) | (487 B) | (155 B) | (758.1 B) | (197.4 B) | (289.3 B) | (228.1 B) | (75.3 B) | (200.1 B) | (181.9 B) | (244.7 B) | (274.8 B) | (116.7 B) | (134.2 B) | (140.9 B) |
| IB5A | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (362.8 M) | (455.6 M) | (397 M) | (275.4 M) | (363.7 M) | (885.7 M) | (589.3 M) | (553.3 M) | (498 M) | (522.9 M) |
| MBJ | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (1.6 B) | (296 M) | (359 M) | (578 M) | (445 M) | (203 M) | (487 M) | (444 M) | (510.6 M) | (536.1 M) |
| MBJ | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (1.6 B) | (296 M) | (359 M) | (578 M) | (445 M) | (203 M) | (487 M) | (444 M) | (510.6 M) | (536.1 M) |
| TZO | (778 K) | (778 K) | (778 K) | (778 K) | (1 M) | (9.6 M) | (2.2 M) | (1.3 M) | (1 M) | (297.6 K) | (654.9 K) | (1.3 M) | (2 M) | (1.2 M) | (1 M) | (1.2 M) | (1.3 M) |
| AJW | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (3.8 B) | (3 B) | (3.8 B) | (4.2 B) | (13.7 B) | (14.7 B) | (7.4 B) | (28.1 B) | (25.3 B) | (24.1 B) |
| 9R5 | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (19.2 M) | (12.2 M) | (10.2 M) | (9.2 M) | (9.6 M) |
ConvaTec Group PLC and related stocks such as Cerence, TELES Informationstech, and BIOTIME Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in ConvaTec Group PLC financial statement analysis. It represents the amount of money remaining after all of ConvaTec Group PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| ConvaTec Group PLC | 2CV |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 20 Eastbourne Terrace, |
| Exchange | Frankfurt Exchange |
EUR 2.64
Other Information on Investing in ConvaTec Stock
ConvaTec Group financial ratios help investors to determine whether ConvaTec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ConvaTec with respect to the benefits of owning ConvaTec Group security.